(Q43801142)

26 November 2017

title

Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein (English)

1 reference

26 November 2017

P L van Haelst

1

1 reference

26 November 2017

J J van Doormaal

2

1 reference

26 November 2017

J F May

3

1 reference

26 November 2017

R O Gans

4

1 reference

26 November 2017

H J Crijns

5

1 reference

26 November 2017

J W Tervaert

6

1 reference

26 November 2017

publication date

1 December 2001

1 reference

European Journal of Internal Medicine

26 November 2017

published in

1 reference

26 November 2017

volume

12

1 reference

26 November 2017

issue

6

1 reference

26 November 2017

page(s)

503-509

1 reference

Atherosclerosis — An Inflammatory Disease

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Cell adhesion molecules in vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during followup

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart diseas

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

The Oslo diet-heart study. Eleven-year report

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Molecular multitasking: statins lead to more arteries, less plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Increased neopterin in patients with chronic and acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Levels of soluble cell adhesion molecules in patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Increasing plasma fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma endothelin-1, factor VII, and neopterin during cholesterol lowering with fluvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900172-8

7 January 2021

10.1016/S0953-6205(01)00172-8

Identifiers

DOI

1 reference

26 November 2017

1 reference